Gold nanoparticles, radiation combo may slow Alzheimer'sJanuary 05, 2006Chemists in Chile and Spain have identified a new approach for the possible treatment of Alzheimer's disease that they say has the potential to destroy beta-amyloid fibrils and plaque - hypothesized to contribute to the mental decline of Alzheimer's patients. The researchers say the new technique, which they call a type of "molecular surgery," could halt or slow the disease's progress without harming healthy brain cells. The research is scheduled for publication in the Jan. 11 issue of the American Chemical Society's Nano Letters. Using test tube studies, the scientists attached gold nanoparticles to a group of beta amyloid fibrils, incubated the resulting mixture for several days and then exposed it to weak microwave fields for several hours. The energy levels of the fields were six times smaller than that of conventional cell phones and unlikely to harm healthy cells, the researchers say. The fibrils subsequently dissolved and remained dissolved for at least one week after being irradiated, indicating that the treatment was not only effective at breaking up the fibrils but also resulted in a lower tendency of the proteins to re-aggregate, according to the researchers. The same approach also holds promise for treating other neurodegenerative diseases that involve protein aggregation, including Parkinson's and Huntington's, says study leader Marcelo J. Kogan, of the University of Chile in Santiago. He says that the approach is similar to that of another experimental technique that uses metallic nanoparticles to label and destroy cancer cells. Animal studies are planned, Kogan says.
There's currently no cure for Alzheimer's disease and no one is sure of its exact causes. The disease affects an estimated 4.5 million people in the United States, according to the National Institute on Aging. That figure is expected to rise dramatically as the population ages, experts predict. The American Chemical Society - the world's largest scientific society - is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio. American Chemical Society | |||||||||||||||||||||
|
Related Alzheimers Current Events and Alzheimers News Articles Families shed light on likely causative gene for Alzheimer's The genetic profile of two large Georgia families with high rates of late-onset Alzheimer's disease points to a gene that may cause the disease, researchers say. Scientists explore consciousness An international team of scientists led by a University of Leicester researcher has carried out a scientific study into the realm of consciousness. High-Trauma Fractures in Older Men and Women Linked to Osteoporosis Researchers at the California Pacific Medical Center (CPMC) Research Institute are challenging a widely held belief that fractures resulting from major trauma, such as automobile accidents, are not related to osteoporosis, the common disease that makes bones weak and prone to fracture. What makes Mars magnetic? Earth's surface is a very active place; its plates are forever jiggling around, rearranging themselves into new configurations. Continents collide and mountains arise, oceans slide beneath continents and volcanoes spew. Cold sore virus might play role in Alzheimer's disease A gene known to be a major risk factor for Alzheimer's disease puts out the welcome mat for the virus that causes cold sores, allowing the virus to be more active in the brain compared to other forms of the gene. Study offers window into human behavior, brain disease UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65. New imaging compound might 'see' Alzheimer's earlier A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the Dec. 21, 2006, issue of the New England Journal of Medicine. Testosterone therapy may prevent Alzheimer's disease Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease. Androgen therapy may slow progress of Alzheimer's disease Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. More Alzheimers Current Events and Alzheimers News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||